# Disruption of Memory Reconsolidating as a Treatment for Panic Disorder

> **NCT02631694** · PHASE2 · UNKNOWN · sponsor: **VU University of Amsterdam** · enrollment: 60 (estimated)

## Conditions studied

- Panic Disorder

## Interventions

- **DRUG:** Propranolol
- **DRUG:** Placebo
- **OTHER:** Carbon dioxide
- **OTHER:** Compressed air

## Key facts

- **NCT ID:** NCT02631694
- **Lead sponsor:** VU University of Amsterdam
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2018-09
- **Final completion:** 2019-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02631694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02631694, "Disruption of Memory Reconsolidating as a Treatment for Panic Disorder". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02631694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*